Position in EBS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$365,962
-$248,511 QoQ
Shares Held
43,671
-41.0% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 194 holders
Holding Since
Sep 2020
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Derivatives in EBS
reported options exposure · as of Sep 30, 2025CallValue
$216,090
CallShares
24,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TRUIST FINANCIAL CORP holds $42,596,492 across 20 Drug Manufacturers - Specialty & Generic names. EBS ranks #14 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
392,480 | $13,297,221 | |
| 2 | ZTS |
Zoetis Inc.
|
116,123 | $8,344,597 | |
| 3 | HLN |
Haleon plc
|
504,080 | $4,703,065 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
6,217 | $3,368,556 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
51,671 | $3,304,360 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
17,951 | $3,025,461 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
71,842 | $1,151,626 | |
| 8 | VTRS |
Viatris Inc
|
61,364 | $974,459 |
All Filings in EBS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $365,962 | 43,671 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $614,473 | 74,033 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $2,712,426 | 219,452 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $216,090 | 24,500 | Call | Defined | 2025-11-03 | |
| 2025-09-30 | $2,375,173 | 269,294 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $2,309,796 | 362,037 | Shares | Defined | 2025-07-18 | |
| 2025-06-30 | $213,730 | 33,500 | Call | Defined | 2025-07-18 | |
| 2025-03-31 | $1,630,184 | 335,429 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $814,444 | 85,193 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $1,204,036 | 144,196 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $897,007 | 131,526 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $296,429 | 117,166 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $272,798 | 113,666 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $374,241 | 110,071 | Shares | Defined | 2023-11-14 | |
| 2021-03-31 | $655,851 | 7,059 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $476,133 | 5,314 | Shares | Defined | 2021-11-19 | |
| 2020-09-30 | $426,337 | 4,126 | Shares | Defined | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||